The prevalence of allergic diseases has dramatically increased among children in recent decades. These conditions significantly impact the quality of life of allergic children and their families. Lactoferrin, a multifunctional glycoprotein found in various biological fluids, is emerging as a promising immunomodulatory agent that can potentially alleviate allergic diseases in children. Lactoferrin's multifaceted properties make it a compelling candidate for managing these conditions. Firstly, lactoferrin exhibits potent anti-inflammatory and antioxidant activities, which can mitigate the chronic inflammation characteristic of allergic diseases. Secondly, its iron-binding capabilities may help regulate the iron balance in allergic children, potentially influencing the severity of their symptoms. Lactoferrin also demonstrates antimicrobial properties, making it beneficial in preventing secondary infections often associated with respiratory allergies. Furthermore, its ability to modulate the immune response and regulate inflammatory pathways suggests its potential as an immune-balancing agent. This review of the current literature emphasises the need for further research to elucidate the precise roles of lactoferrin in allergic diseases. Harnessing the immunomodulatory potential of lactoferrin could provide a novel add-on approach to managing allergic diseases in children, offering hope for improved outcomes and an enhanced quality of life for paediatric patients and their families. As lactoferrin continues to capture the attention of researchers, its properties and diverse applications make it an intriguing subject of study with a rich history and a promising future.
", "publication_date": "2024-06-17", "publisher": "Zenodo", "resource_type": { "id": "publication", "title": { "de": "Publikation", "en": "Publication" } }, "rights": [ { "description": { "en": "The Creative Commons Attribution license allows re-distribution and re-use of a licensed work on the condition that the creator is appropriately credited." }, "icon": "cc-by-icon", "id": "cc-by-4.0", "props": { "scheme": "spdx", "url": "https://creativecommons.org/licenses/by/4.0/legalcode" }, "title": { "en": "Creative Commons Attribution 4.0 International" } } ], "title": "Exploring the Role of Lactoferrin in Managing Allergic Airway Diseases among Children: Unrevealing a Potential Breakthrough" }, "parent": { "access": { "owned_by": { "user": "1282132" }, "settings": { "accept_conditions_text": null, "allow_guest_requests": false, "allow_user_requests": false, "secret_link_expiration": 0 } }, "communities": { "default": "25d73de3-0470-4ea3-b61f-812749f81267", "entries": [ { "access": { "member_policy": "open", "members_visibility": "public", "record_submission_policy": "open", "review_policy": "open", "visibility": "public" }, "children": { "allow": false }, "created": "2021-03-16T10:16:15.961118+00:00", "custom_fields": {}, "deletion_status": { "is_deleted": false, "status": "P" }, "id": "25d73de3-0470-4ea3-b61f-812749f81267", "links": {}, "metadata": { "curation_policy": "In this Community only scientific products by authors affiliated "IRCCS MultiMedica" are accepted.
\r\n", "description": "This community IRCCS MultiMedica collects raw data from studies, projects and publications from own researchers.", "page": "Recognized in 2006 by the Ministry of Health as Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) in the field of Cardiovascular Medicine, IRCCS MultiMedica located in Sesto San Giovanni (Milan) hosts in an area of 24.110 square meters 161 beds, 29 technical heamodialysis beds, 126 ambulatories, 7 surgery rooms where 828 people work (employees and consultants), 181 of whom medical doctors. The second facility is a building of about 10.000 square meters in Via G. Fantoli 16/15, Milan, hosting experimental laboratories entirely dedicated to translational research.
\r\n\r\nThanks to its articulated structure that includes laboratories and therapeutic areas, IRCCS MultiMedica can conduct translational research employing a total of 200 researchers who can integrate clinical practice and experimental research.
\r\n", "title": "IRCCS MultiMedica" }, "revision_id": 0, "slug": "multimedica", "updated": "2021-03-16T10:18:41.959996+00:00" } ], "ids": [ "25d73de3-0470-4ea3-b61f-812749f81267" ] }, "id": "15090107", "pids": {} }, "pids": { "doi": { "identifier": "10.3390/nu16121906", "provider": "external" }, "oai": { "identifier": "oai:zenodo.org:15090108", "provider": "oai" } }, "revision_id": 4, "stats": { "all_versions": { "data_volume": 7689435.0, "downloads": 3, "unique_downloads": 2, "unique_views": 15, "views": 15 }, "this_version": { "data_volume": 7689435.0, "downloads": 3, "unique_downloads": 2, "unique_views": 15, "views": 15 } }, "status": "published", "swh": {}, "updated": "2025-03-26T14:18:16.647020+00:00", "versions": { "index": 1, "is_latest": true } }